SupremeToday Landscape Ad
Back
Next
Judicial Analysis Court Copy Headnote Facts Arguments Court observation
Listen Audio Icon Pause Audio Icon
judgment-img

2023 Supreme(Del) 3073

C. HARI SHANKAR
Merck Sharp And Dohme Corp – Appellant
Versus
Neptune Life Sciences Pvt. Ltd. – Respondent


Advocates appeared:
Mr. Pravin Anand, Advocate, for the Plaintiff.

JUDGMENT (Oral)

1. The plaintiff, by this suit, alleged infringement, by the defendants, of Indian Patent No. 209816, whereunder the drug Sitagliptin was patented in favour of the plaintiff. The life of the suit patent expired on 5 July 2022. The plaintiff alleged, in the plaint, that Defendant 1 was manufacturing and Defendant 2 was distributing, pharmaceutical generic versions of Sitagliptin, without obtaining a license from the plaintiff, under trade name "HAPPY JAAN M". The plaint has also provided, in para 42, a photograph of a strip of HAPPY JAAN M, which is a combination of Sitagliptin Phosphate and Metformin Hydrochloride. The strip is shown to be manufactured by Defendant 1 Neptune Life Sciences Pvt. Ltd. and distributed by Defendant 2 Happy Drugs. It is also seen that the strip is from the Batch bearing Batch No. TN - 6084, manufactured in March 2021 with expiry February 2023. As such, it is apparent from the strip in question that a product containing Sitagliptin was indeed manufactured by Defendant 1 and marketed/distributed by Defendant 2, during the time the suit patent was still alive and subsisting.

2. Consequent on issuance of summons, Defendant 2 has consistentl

Click Here to Read the rest of this document
1
2
3
4
5
6
7
8
9
10
11
SupremeToday Portrait Ad
supreme today icon
logo-black

An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers

Please visit our Training & Support
Center or Contact Us for assistance

qr

Scan Me!

India’s Legal research and Law Firm App, Download now!

For Daily Legal Updates, Join us on :

whatsapp-icon telegram-icon
whatsapp-icon Back to top